Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
21.5 HKD | -1.15% | +8.40% | +5.38% |
Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
- Stock Market
- Equities
- 1099 Stock
- News Sinopharm Group Co. Ltd.